AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Chiome Bioscience Inc.
  3. Financials
  4. Total non-current liabilities

Chiome Bioscience Inc.【JP:4583】

Market cap
¥7.4B
P/E ratio
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal non-current liabilities (Million JPY)YoY (%)
Dec 31, 2025231+318.28%
Dec 31, 202455+0.78%
Dec 31, 202355+0.78%
Dec 31, 202254+0.78%
Dec 31, 202154+28.61%
Dec 31, 202042+1.02%
Dec 31, 201941+1.02%
Dec 31, 201841+1.02%
Dec 31, 201741-26.14%
Dec 31, 201655-53.01%
Dec 31, 2015117+85.03%
Dec 31, 201463

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)